| Clozapine treatment for suicidality in schizophrenia: international suicide prevention trial (InterSePT) HY Meltzer, L Alphs, AI Green, AC Altamura, R Anand, A Bertoldi, ... Archives of general psychiatry 60 (1), 82-91, 2003 | 1691 | 2003 |
| A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients G Chouinard, B Jones, G Remington, D Bloom, D Addington, ... Journal of clinical psychopharmacology 13 (1), 25-40, 1993 | 1240 | 1993 |
| The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials SR Marder, JM Davis, G Chouinard J Clin Psychiatry 58 (12), 538-546, 1997 | 918 | 1997 |
| Extrapyramidal rating scale G Chouinard Can. J. Neurol. Sci. 7, 233, 1980 | 883 | 1980 |
| Manual for the extrapyramidal symptom rating scale (ESRS) G Chouinard, HC Margolese Schizophrenia research 76 (2-3), 247-265, 2005 | 440 | 2005 |
| Elevated dopa decarboxylase activity in living brain of patients with psychosis ANDAG J. REITH, C. BENKELFAT, A. SHERWIN, Y. YASUHARA, H. KUWABARA, F ... Proc. Nadl. Acad. Sci. 91 (November), 11651-11654, 1994 | 437* | 1994 |
| Placebo-controlled study of gabapentin treatment of panic disorder AC Pande, MH Pollack, J Crockatt, M Greiner, G Chouinard, RB Lydiard, ... Journal of clinical psychopharmacology 20 (4), 467-471, 2000 | 423 | 2000 |
| Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics G Chouinard, BD Jones Am J Psychiatry 137 (1), 16-21, 1980 | 419 | 1980 |
| Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound G Chouinard Journal of Clinical Psychiatry 65, 7-12, 2004 | 414 | 2004 |
| Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder J Greist, G Chouinard, E DuBoff, A Halaris, SW Kim, L Koran, M Liebowitz, ... Archives of General Psychiatry 52 (4), 289-295, 1995 | 406 | 1995 |
| Antidepressant efficacy of sertraline: a double-blind, placebo-and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. FW Reimherr, G Chouinard, CK Cohn, JO Cole, TM Itil, YD LaPierre, ... The Journal of clinical psychiatry 51, 18-27, 1990 | 356 | 1990 |
| Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients AM Ghadirian, G Chouinard, L Annable The Journal of nervous and mental disease 170 (8), 463-467, 1982 | 341 | 1982 |
| Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study G Chouinard, L Annable, R Fontaine, L Solyom Psychopharmacology 77, 229-233, 1982 | 341 | 1982 |
| Neuroleptic-induced supersensitivity psychosis. G Chouinard, BD Jones, L Annable The American journal of psychiatry, 1978 | 276 | 1978 |
| Risperidone in the treatment of Tourette syndrome: a double-blind, placebo-controlled trial Y Dion, L Annable, P Sandor, G Chouinard Journal of clinical psychopharmacology 22 (1), 31-39, 2002 | 268 | 2002 |
| Antimanic effect of clonazepam. G Chouinard, SN Young, L Annable Biological psychiatry 18 (4), 451-466, 1983 | 259 | 1983 |
| Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. G Chouinard, W Goodman, J Greist, M Jenike, S Rasmussen, K White, ... Psychopharmacology bulletin 26 (3), 279-284, 1990 | 238 | 1990 |
| Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment R Fontaine, G Chouinard, L Annable Am J Psychiatry 141 (7), 848-852, 1984 | 238 | 1984 |
| Antipsychotic-induced dopamine supersensitivity psychosis: pharmacology, criteria, and therapy G Chouinard, AN Samaha, VA Chouinard, CS Peretti, N Kanahara, ... Psychotherapy and psychosomatics 86 (4), 189-219, 2017 | 236 | 2017 |
| A comparison of venlafaxine, trazodone, and placebo in major depression LA Cunningham, RL Borison, JS Carman, G Chouinard, JE Crowder, ... Journal of clinical psychopharmacology 14 (2), 99-106, 1994 | 220 | 1994 |
